Kazia Therapeutics (KZIA) Total Non-Current Liabilities (2017 - 2025)
Kazia Therapeutics (KZIA) has disclosed Total Non-Current Liabilities for 6 consecutive years, with $197893.9 as the latest value for Q2 2025.
- For the quarter ending Q2 2025, Total Non-Current Liabilities fell 94.83% year-over-year to $197893.9, compared with a TTM value of $197893.9 through Jun 2025, down 94.83%, and an annual FY2025 reading of $200272.0, down 94.74% over the prior year.
- Total Non-Current Liabilities was $197893.9 for Q2 2025 at Kazia Therapeutics, down from $3.8 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $7.8 million in Q2 2022 and bottomed at $197893.9 in Q2 2025.
- Average Total Non-Current Liabilities over 4 years is $4.4 million, with a median of $4.7 million recorded in 2024.
- The sharpest move saw Total Non-Current Liabilities fell 27.41% in 2023, then crashed 94.83% in 2025.
- Year by year, Total Non-Current Liabilities stood at $7.8 million in 2022, then dropped by 27.41% to $5.7 million in 2023, then tumbled by 32.41% to $3.8 million in 2024, then plummeted by 94.83% to $197893.9 in 2025.
- Business Quant data shows Total Non-Current Liabilities for KZIA at $197893.9 in Q2 2025, $3.8 million in Q2 2024, and $5.7 million in Q2 2023.